MMP9 has previously been shown to be produced by podocytes, and it is altered in several glomerular diseases, supporting the conclusion that Vangl2 modulates glomerular injury by stopping MMP9 production [48]. The gene discussed is VANGL2; the disease is glomerular disorder.